What is the recommended treatment for periodic limb movements occurring in both non‑rapid eye movement (NREM) and rapid eye movement (REM) sleep, not associated with respiratory events, with elevated muscle tone observed during REM?

Elevated Muscle Tone in REM with PLMs: Evaluate for REM Sleep Behavior Disorder First

The presence of periodic limb movements in both NREM and REM sleep with elevated muscle tonicity during REM is highly concerning for REM sleep behavior disorder (RBD) rather than isolated PLMD, and requires immediate evaluation to rule out RBD before initiating treatment for periodic limb movements.

Critical Diagnostic Distinction

The clinical scenario described—PLMs occurring in REM sleep with elevated muscle tone—is not typical of isolated PLMD. According to the 2025 AASM guidelines, PLMD diagnosis specifically requires the absence of sleep disorders associated with high rates of PLMS, including REM sleep behavior disorder 1.

Key Red Flags Present:

• Elevated muscle tone during REM sleep (REM sleep without atonia)
• PLMs occurring in REM sleep (typically absent in uncomplicated PLMD)
• This constellation strongly suggests RBD or REM sleep without atonia 2

Why This Matters for Morbidity and Mortality

RBD carries significantly different implications than PLMD:

• Strong association with synucleinopathies (Parkinson's disease, multiple system atrophy, Lewy body dementia)
• Risk of injury to patient and bed partner from dream enactment behaviors
• Different treatment approach than isolated PLMD

Research demonstrates that vigorous PLMS can mimic RBD symptomatology, with patients displaying kicking, punching, and even injuring bed partners during arousals following PLMS 3. However, these cases showed normal REM atonia on polysomnography—the critical distinguishing feature.

Recommended Diagnostic Approach

Immediate Steps:

1. Review polysomnography for REM sleep without atonia

   • Quantify chin EMG tone during REM sleep
   • Assess for phasic and tonic muscle activity in REM
   • Document any complex motor behaviors during REM

2. Detailed clinical history focusing on:

   • Dream enactment behaviors (acting out dreams)
   • Violent or injurious movements during sleep
   • Bed partner observations of complex behaviors vs. simple limb jerks
   • Timing of movements (PLMS typically first 4 hours; RBD throughout night)

3. Neurological evaluation if RBD confirmed

   • Screen for early parkinsonian features
   • Consider neurodegenerative disease risk assessment

Treatment Algorithm

If RBD is Present (elevated REM tone confirmed):

• Melatonin is first-line for RBD (not addressed in PLMD guidelines)
• Clonazepam as alternative
• Safety measures are paramount (remove dangerous objects, mattress on floor)
• Do not treat as isolated PLMD

If RBD is Ruled Out (normal REM atonia despite PLMs in REM):

This represents the unusual scenario of PLMD with PLMs extending into REM sleep 3. Treatment follows standard PLMD guidelines:

First-Line Pharmacologic Options (per 2025 AASM guidelines):

1. Alpha-2-delta ligands (preferred given recent downgrading of dopamine agonists)

   • Gabapentin enacarbil
   • Pregabalin
   • Standard gabapentin

2. Dopamine agonists (conditional recommendations, monitor for augmentation)

   • Pramipexole and ropinirole are most effective for PLMS suppression 4
   • However, 2025 guidelines downgraded long-term dopamine agonist use due to augmentation risk 5
   • Consider for severe cases unresponsive to alpha-2-delta ligands

3. Iron supplementation

   • Check ferritin and iron studies first
   • IV iron (ferric carboxymaltose) if deficient, though monitor for hypophosphatemia 5

Medications to Avoid:

• Valproic acid (AASM suggests against) 1
• Triazolam (AASM suggests against) 1

Common Pitfalls

1. Assuming all PLMs are benign PLMD without evaluating REM muscle tone—this misses potentially serious RBD
2. Starting dopamine agonists without considering augmentation risk—the 2025 guidelines specifically downgraded these due to long-term complications 5
3. Not checking iron status before pharmacologic treatment—iron deficiency is a treatable cause
4. Ignoring the clinical significance question—PLMD requires documented sleep disturbance or daytime dysfunction, not just polysomnographic findings 1

Bottom Line

Do not proceed with PLMD treatment until RBD is definitively excluded through careful review of REM muscle tone on polysomnography. The elevated muscle tonicity during REM described in your question is the critical feature that demands this evaluation, as it fundamentally changes diagnosis, prognosis, and treatment approach with significant implications for long-term neurological health.